4//SEC Filing
Hoverman Daniel S. 4
Accession 0001493152-18-006672
CIK 0001362703other
Filed
May 10, 8:00 PM ET
Accepted
May 11, 4:56 PM ET
Size
5.6 KB
Accession
0001493152-18-006672
Insider Transaction Report
Form 4
Hoverman Daniel S.
Director
Transactions
- Award
Option (right to buy)
2018-05-09+3,000,000→ 3,350,000 totalExercise: $0.01From: 2019-05-09Exp: 2028-05-09→ Common Stock (3,000,000 underlying)
Footnotes (1)
- [F1]Options issued as compensation approved by the Issuer's Board of Directors.
Documents
Issuer
OncBioMune Pharmaceuticals, Inc
CIK 0001362703
Entity typeother
Related Parties
1- filerCIK 0001665931
Filing Metadata
- Form type
- 4
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 4:56 PM ET
- Size
- 5.6 KB